Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Data support development of Vical's gene-based cancer therapies

Dec. 19, 2000

Schering AG and Jenapharm jointly develop highly potent, selective and pure progesterone antagonist

Dec. 19, 2000

Large group of MEK-inhibitory quinolines discovered at AstraZeneca

Dec. 18, 2000

Potent MMP inhibitor delays osteolytic disease associated with breast cancer metastasis

Dec. 18, 2000

S-1 appears to safely improve survival in metastatic breast cancer patients

Dec. 18, 2000

Arzoxifene has identical effects to tamoxifen in endometrial cancer models

Dec. 18, 2000

EntreMed commences phase I trial of Angiostatin by s.c. injection

Dec. 18, 2000

Cytochroma collaborates with Johns Hopkins on vitamin D-related drug discovery

Dec. 18, 2000

ODAC unanimously recommends approval of Femara as first-line breast cancer treatment

Dec. 15, 2000

New progesterone receptor modulators continue to emerge from AHP/Ligand alliance

Dec. 15, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...